Sandra Huguenin

Sandra Huguenin has been in the clinical research field since 2005. Sandra began their career at Melys as a Manager for Scientific and Medical, National and International Conferences in 2005. In 2007, they moved to ClinResearch as a Clinical Research Associate. From 2010 to 2015, Sandra worked at ICON plc in various roles, including Associate Clinical Trial Manager, Lead Clinical Research Associate, and Clinical Research Associate II and Senior Clinical Research Associate. In 2015, they joined Covance Periapproval Services Inc. as an Associated Project Manager. In 2018, they moved to TFS Trial Form Support GmbH for AstraZeneca as a Senior Project Manager. In 2020, they transitioned to Labcorp Clinical Development GmbH as a Clinical Research Manager. Currently, Sandra is a Senior Clinical Project Manager at Topas Therapeutics GmbH.

Sandra Huguenin obtained their Bachelor of Science in Biochemistry from the University of Paris 7 in Paris, France from 1992 to 1994. Sandra then completed a Master of Science Degree in Cellular and Molecular Biology from the University of Strasbourg 1 in Strasbourg, France from 1994 to 1995. In 1996, they earned a Master of Science Degree in Quality and Physico-Chemistry of Bio-products from the Institut National Agronomique Paris-Grignon (INAPG) in Paris, France. In 2002, they obtained a University Diploma in Biological and Medical Engineering from the University of Paris 6 in Paris, France with a report on “Patents and strategic information management: key elements for companies strategy”. Finally, they earned their Doctor of Philosophy in Cellular and Molecular Biology from the University of Paris 12 in Creteil, France from 1997 to 2004.